REGENXBIO Inc.
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
86.91 |
316.89 |
272.31 |
300.64 |
518.74 |
714.58 |
| Przychód Δ r/r |
0.00% |
264.64% |
-14.07% |
10.40% |
72.54% |
37.75% |
| Przychód (min) |
79.05 |
265.05 |
88.10 |
298.02 |
277.04 |
381.63 |
| Przychód (max) |
89.72 |
378.02 |
463.21 |
303.27 |
714.55 |
984.33 |
| EBITDA (średnia) |
-56.77 |
-206.99 |
-177.87 |
-196.38 |
-338.84 |
-466.77 |
| EBIT (średnia) |
-58.07 |
-211.73 |
-181.94 |
-200.87 |
-346.59 |
-477.45 |
| EBIT % |
-66.81% |
-66.81% |
-66.81% |
-66.81% |
-66.81% |
-66.81% |
| Zysk netto (średni) |
-233.27 |
-14.50 |
-111.45 |
-95.04 |
-37.03 |
110.50 |
| Zysk netto % |
-268.42% |
-4.57% |
-40.93% |
-31.61% |
-7.14% |
15.46% |
| EPS (średnia) |
-4.73 |
-0.29 |
-1.52 |
-2.10 |
-0.75 |
2.23 |
| Liczba analityków (Przychody) |
9 |
8 |
11 |
7 |
4 |
3 |
| Liczba analityków (EPS) |
7 |
6 |
9 |
7 |
5 |
2 |
| symbol |
RGNX |
RGNX |
RGNX |
RGNX |
RGNX |
RGNX |